These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

66 related items for PubMed ID: 13500986

  • 21. [Psychopathological problems with neuroleptically treated schizophrenic verbal hallucinations].
    SIMKO A.
    Nervenarzt; 1959 Jun 20; 30(6):274-7. PubMed ID: 13674504
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. [Clinical experiences in reserpine therapy of schizophrenic psychoses with special reference to the relationship somatic findings & EEG].
    BAYREUTHER H, RADTKE H.
    Arch Psychiatr Nervenkr Z Gesamte Neurol Psychiatr; 1958 Jun 20; 198(2):158-80. PubMed ID: 13606842
    [No Abstract] [Full Text] [Related]

  • 27. [Reconsideration of reserpine in the treatment of schizophrenia].
    Kubo S, Kodama H, Kimura N.
    Iryo; 1968 May 20; 22(5):578-82. PubMed ID: 5699914
    [No Abstract] [Full Text] [Related]

  • 28. [Evaluation of the effectiveness of psychotherapy of psychoses].
    Zakowska-Dabrowska T, Jankowska H.
    Psychiatr Pol; 1979 May 20; 13(4):357-63. PubMed ID: 390580
    [No Abstract] [Full Text] [Related]

  • 29. [Further contributions to study of the therapeutic effects of combined reserpine and orphenadrine in massive doses in chronic schizophrenia].
    BALLERINI A, GERMANO G.
    Rass Studi Psichiatr; 1961 May 20; 50():215-20. PubMed ID: 13686389
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. [The recall of dreams after administration of reserpine in chronic schizophrenics treated with prefrontal lobotomy].
    Jus A, Jus K, Gautier J, Villeneuve A, Pires P, Lachance R, Villeneuve R.
    Vie Med Can Fr; 1973 Sep 20; 2(9):843-8. PubMed ID: 4761479
    [No Abstract] [Full Text] [Related]

  • 33. [Current status of the treatment of schizophrenia with chlorpromazine and reserpine].
    COULLAUT MENDIGUTIA R, COLINA LEONES MJ.
    Rev Clin Esp; 1956 Dec 15; 63(5):315-29. PubMed ID: 13420828
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Reserpine added to neuroleptic-tricyclic in refractory schizophrenics.
    Bacher N, Lewis H.
    J Clin Psychiatry; 1981 Aug 15; 42(8):326. PubMed ID: 7019202
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. [The influence of iprazid and reserpine on the effect of lysergic acid diethylamide].
    Stoliarov GV.
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1966 Aug 15; 66(10):1571-4. PubMed ID: 6000322
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 4.